Who should watch this?: Biologists, Genomics Core Professionals, Researchers, Drug Developers, BioInformaticians

How long is the event?: 45 minutes of content with Q&A afterwards
(send your questions to connect@rosalind.bio)

Presented By:

Ryan Friese, Ph.D.

Director of Customer Success

Rosalind, Inc

          Having been fortunate enough to enter the precision medicine field while it was still in its infancy, Dr. Ryan Friese has proudly played a role in its rapid growth. His career began in the Bioengineering Department at the University of California San Diego, focused on uncovering the genetic basis of cardiovascular disease. Ultimately, his work culminated with development of novel antagomir and small molecule therapeutics for essential hypertension.
After leaving academia for the biotech industry, Dr. Friese switched to development of molecular diagnostics for hereditary cancer. Part of that work involved a collaboration with IBM, using their Watson Artificial Intelligence (AI) system to develop a personalized medicine app for patients. Later at NanoString, Dr. Friese assisted the Pharma and Biotech industry in southern California with their drug development, clinical trial, and biomarker studies. He also developed expertise in GeoMx spatial transcriptomics assays, proteomics assays, and data analysis pipelines.

          When presented with an opening at ROSALIND, Dr. Friese jumped at the opportunity to get involved at the forefront of cloud computing and artificial intelligence, the next frontiers in science and technology. He is excited to help researchers across the globe utilize ROSALIND to find novel insights and discover that next, big scientific breakthrough

Isabella Vahrson

BioInformatics Scientist

Rosalind, Inc

          Isabella is part of the data science and AI team at ROSALIND. She has a comprehensive scientific background with experience in biomedical sciences, bioinformatics, and cellular and molecular biology. Prior to joining ROSALIND, Isabella worked as a researcher in the fields of microbial evolution, immunology, and neuroendocrinology. She now utilizes her experience to support the continued improvement of ROSALIND, by working to expand the platform's capabilities across new technologies and data types.